CRISPR & the Forbidden Genome: Editing Ethics and the Superhuman Arms Race cover art

CRISPR & the Forbidden Genome: Editing Ethics and the Superhuman Arms Race

CRISPR & the Forbidden Genome: Editing Ethics and the Superhuman Arms Race

Listen for free

View show details

About this listen

 In this cinematic episode of Cold Logic, Silas Gray pulls back the veil on the explosive frontier of human alteration: CRISPR and the Forbidden Genome. Once the stuff of speculative fiction, genome editing is now real, precise, and inheritable—and the global conversation over who gets to rewrite humanity is fracturing. From the medical breakthrough of CRISPR-based therapies like Casgevy that are curing sickle cell disease and beta-thalassemia, to the scandal of the “CRISPR babies” and the uneasy comeback of He Jiankui, this episode traces the scientific, ethical, geopolitical, and human stakes in the emerging superhuman arms race. We dig into the international push for a moratorium on heritable human genome editing, the fractured governance landscape (including WHO’s frameworks), the rise of clandestine enhancement programs and black-market editing, and the risk of biological inequality as enhancement becomes a new axis of power. Through storytelling, expert context, and sobering reflection, Cold Logic asks: once you can edit the code of life, who decides what’s allowed, what’s enhanced, and what gets erased? Listeners will come away with a clear map of the tools (CRISPR, base and prime editing), the controversies, the proposed global social contract, and actionable steps to engage—because the future of humanity’s genome shouldn’t be written behind closed doors.

#CRISPR #ForbiddenGenome #ColdLogicPodcast #SilasGray #GenomeEditing #SuperhumanArmsRace #HeJiankui #Casgevy #EthicsInBiotech #HeritableEditing #MoratoriumOnHHGE #GeneticGovernance #Bioethics #WHOGenomeFramework #EnhancementVsTherapy #BiologicalInequality #GeneEditingRegulation #GenomeSocialContract #Biosecurity #HumanUpgrade Sources & Key References:
  • FDA approval of CRISPR-based therapies (Casgevy and Lyfgenia) for sickle cell disease and beta-thalassemia, marking the first clinical deployment of human genome editing for inherited disorders. U.S. Food and Drug AdministrationASGCTPubMedAxiosTIMEInvestopedia
  • Background and fallout of the 2018 “CRISPR babies” experiment by He Jiankui, including analysis of ethical breaches and his return to research, raising questions about norm fragility. PMCThe GuardianTaylor & Francis Online
  • International calls (2025) for a 10-year moratorium on heritable human genome editing to allow global ethical consensus and prevent premature enhancement escalation.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.